NASDAQ:MESO

Mesoblast Stock Insider Trading

etoro logo Buy MESO
*Your capital is at risk
$14.17
-0.380 (-2.61%)
At Close: Jul 31, 2026

Mesoblast Stock Insider Power

Based on the 79 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 32.04M and sold 0 MESO shares in the last 79 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 79 transactions)
100.00
Buy 32.04M shares
Sell 0 shares
100% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Nov 17, 2022
Buy
Option (right to buy)
Burns William Murray
Director
Director 33 334
Value: $60.3K
Nov 17, 2022
Buy
Option (right to buy)
Rose Eric Allen
Chief Medical Officer,director
Officer 33 334
Value: $60.3K
Mar 18, 2021
Buy
Warrants
Facchina Philip James
Director
Director 68 306
Value: $195.4K
Mar 18, 2021
Buy
Warrants
George Gregory
Director
Director 6 830 602
Value: $19.5M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MESOBLAST LTD
Mesoblast
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchyma...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE